These findings were accompanied by trends toward improvement in renal function and systemic inflammation biomarkers in the SGLT2i group, although these changes did not reach statistical significance.
← all excerpts
Depot-Specific Cardiorenal Adipose Remodeling with SGLT2i in Chronic Kidney Disease.
1
—
—